Selected research
Market Outlook & Growth Opportunities
Global Radiation Oncology Devices Market Outlook and Growth Opportunities 2026
Market perspective
The global Radiation Oncology Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Radiation Oncology Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Radiation Oncology Devices market include ZEISS, Viewray Technologies, Inc, Theragenics, Siemens Healthineers AG, Sensus Healthcare, Inc, P-cure, Panacea Medical Technologies Pvt. Ltd, Optivus Proton Therapy and Mevion Medical Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Radiation Oncology Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radiation Oncology Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radiation Oncology Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiation Oncology Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Radiation Oncology Devices Segment by Company
ZEISS
Viewray Technologies, Inc
Theragenics
Siemens Healthineers AG
Sensus Healthcare, Inc
P-cure
Panacea Medical Technologies Pvt. Ltd
Optivus Proton Therapy
Mevion Medical Systems
IsoRay
Ion Beam Applications
Intraop Medical
GT Medical Technologies, Inc
Elekta AB
Eckert & Ziegler Bebig
C.R. Bard
Accuray Incorporated
Radiation Oncology Devices Segment by Type
External Beam Therapy Devices
Internal Beam Therapy Devices
Radiation Oncology Devices Segment by Application
Breast Cancer
Prostate Cancer
Cervical Cancer
Others
Radiation Oncology Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Radiation Oncology Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Radiation Oncology Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Radiation Oncology Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Radiation Oncology Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Oncology Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiation Oncology Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Oncology Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiation Oncology Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiation Oncology Devices industry.
Chapter 3: Detailed analysis of Radiation Oncology Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Radiation Oncology Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Radiation Oncology Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- External Beam Therapy Devices
- Internal Beam Therapy Devices
Applications
- Breast Cancer
- Prostate Cancer
- Cervical Cancer
- Others
Companies covered
- ZEISS
- Viewray Technologies, Inc
- Theragenics
- Siemens Healthineers AG
- Sensus Healthcare, Inc
- P-cure
- Panacea Medical Technologies Pvt. Ltd
- Optivus Proton Therapy
- Mevion Medical Systems
- IsoRay
- Ion Beam Applications
- Intraop Medical
- GT Medical Technologies, Inc
- Elekta AB
- Eckert & Ziegler Bebig
- C.R. Bard
- Accuray Incorporated
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Radiation Oncology Devices Sales Value (2021-2032)
- 1.2.2 Global Radiation Oncology Devices Sales Volume (2021-2032)
- 1.2.3 Global Radiation Oncology Devices Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Radiation Oncology Devices Market Dynamics
- 2.1 Radiation Oncology Devices Industry Trends
- 2.2 Radiation Oncology Devices Industry Drivers
- 2.3 Radiation Oncology Devices Industry Opportunities and Challenges
- 2.4 Radiation Oncology Devices Industry Restraints
3 Radiation Oncology Devices Market by Company
- 3.1 Global Radiation Oncology Devices Company Revenue Ranking in 2025
- 3.2 Global Radiation Oncology Devices Revenue by Company (2021-2026)
- 3.3 Global Radiation Oncology Devices Sales Volume by Company (2021-2026)
- 3.4 Global Radiation Oncology Devices Average Price by Company (2021-2026)
- 3.5 Global Radiation Oncology Devices Company Ranking (2024-2026)
- 3.6 Global Radiation Oncology Devices Company Manufacturing Base and Headquarters
- 3.7 Global Radiation Oncology Devices Company Product Type and Application
- 3.8 Global Radiation Oncology Devices Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Radiation Oncology Devices Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Radiation Oncology Devices Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Radiation Oncology Devices Market by Type
- 4.1 Radiation Oncology Devices Type Introduction
- 4.1.1 External Beam Therapy Devices
- 4.1.2 Internal Beam Therapy Devices
- 4.2 Global Radiation Oncology Devices Sales Volume by Type
- 4.2.1 Global Radiation Oncology Devices Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radiation Oncology Devices Sales Volume by Type (2021-2032)
- 4.2.3 Global Radiation Oncology Devices Sales Volume Share by Type (2021-2032)
- 4.3 Global Radiation Oncology Devices Sales Value by Type
- 4.3.1 Global Radiation Oncology Devices Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radiation Oncology Devices Sales Value by Type (2021-2032)
- 4.3.3 Global Radiation Oncology Devices Sales Value Share by Type (2021-2032)
5 Radiation Oncology Devices Market by Application
- 5.1 Radiation Oncology Devices Application Introduction
- 5.1.1 Breast Cancer
- 5.1.2 Prostate Cancer
- 5.1.3 Cervical Cancer
- 5.1.4 Others
- 5.2 Global Radiation Oncology Devices Sales Volume by Application
- 5.2.1 Global Radiation Oncology Devices Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radiation Oncology Devices Sales Volume by Application (2021-2032)
- 5.2.3 Global Radiation Oncology Devices Sales Volume Share by Application (2021-2032)
- 5.3 Global Radiation Oncology Devices Sales Value by Application
- 5.3.1 Global Radiation Oncology Devices Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radiation Oncology Devices Sales Value by Application (2021-2032)
- 5.3.3 Global Radiation Oncology Devices Sales Value Share by Application (2021-2032)
6 Radiation Oncology Devices Regional Sales and Value Analysis
- 6.1 Global Radiation Oncology Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radiation Oncology Devices Sales by Region (2021-2032)
- 6.2.1 Global Radiation Oncology Devices Sales by Region: 2021-2026
- 6.2.2 Global Radiation Oncology Devices Sales by Region (2027-2032)
- 6.3 Global Radiation Oncology Devices Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Radiation Oncology Devices Sales Value by Region (2021-2032)
- 6.4.1 Global Radiation Oncology Devices Sales Value by Region: 2021-2026
- 6.4.2 Global Radiation Oncology Devices Sales Value by Region (2027-2032)
- 6.5 Global Radiation Oncology Devices Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Radiation Oncology Devices Sales Value (2021-2032)
- 6.6.2 North America Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Radiation Oncology Devices Sales Value (2021-2032)
- 6.7.2 Europe Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Radiation Oncology Devices Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Radiation Oncology Devices Sales Value (2021-2032)
- 6.9.2 South America Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Radiation Oncology Devices Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
7 Radiation Oncology Devices Country-level Sales and Value Analysis
- 7.1 Global Radiation Oncology Devices Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Radiation Oncology Devices Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Radiation Oncology Devices Sales by Country (2021-2032)
- 7.3.1 Global Radiation Oncology Devices Sales by Country (2021-2026)
- 7.3.2 Global Radiation Oncology Devices Sales by Country (2027-2032)
- 7.4 Global Radiation Oncology Devices Sales Value by Country (2021-2032)
- 7.4.1 Global Radiation Oncology Devices Sales Value by Country (2021-2026)
- 7.4.2 Global Radiation Oncology Devices Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.9.2 France Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.16.2 China Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.19.2 India Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ZEISS
- 8.1.1 ZEISS Company Information
- 8.1.2 ZEISS Business Overview
- 8.1.3 ZEISS Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.1.4 ZEISS Radiation Oncology Devices Product Portfolio
- 8.1.5 ZEISS Recent Developments
- 8.2 Viewray Technologies, Inc
- 8.2.1 Viewray Technologies, Inc Company Information
- 8.2.2 Viewray Technologies, Inc Business Overview
- 8.2.3 Viewray Technologies, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Viewray Technologies, Inc Radiation Oncology Devices Product Portfolio
- 8.2.5 Viewray Technologies, Inc Recent Developments
- 8.3 Theragenics
- 8.3.1 Theragenics Company Information
- 8.3.2 Theragenics Business Overview
- 8.3.3 Theragenics Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Theragenics Radiation Oncology Devices Product Portfolio
- 8.3.5 Theragenics Recent Developments
- 8.4 Siemens Healthineers AG
- 8.4.1 Siemens Healthineers AG Company Information
- 8.4.2 Siemens Healthineers AG Business Overview
- 8.4.3 Siemens Healthineers AG Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers AG Radiation Oncology Devices Product Portfolio
- 8.4.5 Siemens Healthineers AG Recent Developments
- 8.5 Sensus Healthcare, Inc
- 8.5.1 Sensus Healthcare, Inc Company Information
- 8.5.2 Sensus Healthcare, Inc Business Overview
- 8.5.3 Sensus Healthcare, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Sensus Healthcare, Inc Radiation Oncology Devices Product Portfolio
- 8.5.5 Sensus Healthcare, Inc Recent Developments
- 8.6 P-cure
- 8.6.1 P-cure Company Information
- 8.6.2 P-cure Business Overview
- 8.6.3 P-cure Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.6.4 P-cure Radiation Oncology Devices Product Portfolio
- 8.6.5 P-cure Recent Developments
- 8.7 Panacea Medical Technologies Pvt. Ltd
- 8.7.1 Panacea Medical Technologies Pvt. Ltd Company Information
- 8.7.2 Panacea Medical Technologies Pvt. Ltd Business Overview
- 8.7.3 Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Product Portfolio
- 8.7.5 Panacea Medical Technologies Pvt. Ltd Recent Developments
- 8.8 Optivus Proton Therapy
- 8.8.1 Optivus Proton Therapy Company Information
- 8.8.2 Optivus Proton Therapy Business Overview
- 8.8.3 Optivus Proton Therapy Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Optivus Proton Therapy Radiation Oncology Devices Product Portfolio
- 8.8.5 Optivus Proton Therapy Recent Developments
- 8.9 Mevion Medical Systems
- 8.9.1 Mevion Medical Systems Company Information
- 8.9.2 Mevion Medical Systems Business Overview
- 8.9.3 Mevion Medical Systems Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Mevion Medical Systems Radiation Oncology Devices Product Portfolio
- 8.9.5 Mevion Medical Systems Recent Developments
- 8.10 IsoRay
- 8.10.1 IsoRay Company Information
- 8.10.2 IsoRay Business Overview
- 8.10.3 IsoRay Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.10.4 IsoRay Radiation Oncology Devices Product Portfolio
- 8.10.5 IsoRay Recent Developments
- 8.11 Ion Beam Applications
- 8.11.1 Ion Beam Applications Company Information
- 8.11.2 Ion Beam Applications Business Overview
- 8.11.3 Ion Beam Applications Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Ion Beam Applications Radiation Oncology Devices Product Portfolio
- 8.11.5 Ion Beam Applications Recent Developments
- 8.12 Intraop Medical
- 8.12.1 Intraop Medical Company Information
- 8.12.2 Intraop Medical Business Overview
- 8.12.3 Intraop Medical Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Intraop Medical Radiation Oncology Devices Product Portfolio
- 8.12.5 Intraop Medical Recent Developments
- 8.13 GT Medical Technologies, Inc
- 8.13.1 GT Medical Technologies, Inc Company Information
- 8.13.2 GT Medical Technologies, Inc Business Overview
- 8.13.3 GT Medical Technologies, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.13.4 GT Medical Technologies, Inc Radiation Oncology Devices Product Portfolio
- 8.13.5 GT Medical Technologies, Inc Recent Developments
- 8.14 Elekta AB
- 8.14.1 Elekta AB Company Information
- 8.14.2 Elekta AB Business Overview
- 8.14.3 Elekta AB Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Elekta AB Radiation Oncology Devices Product Portfolio
- 8.14.5 Elekta AB Recent Developments
- 8.15 Eckert & Ziegler Bebig
- 8.15.1 Eckert & Ziegler Bebig Company Information
- 8.15.2 Eckert & Ziegler Bebig Business Overview
- 8.15.3 Eckert & Ziegler Bebig Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Eckert & Ziegler Bebig Radiation Oncology Devices Product Portfolio
- 8.15.5 Eckert & Ziegler Bebig Recent Developments
- 8.16 C.R. Bard
- 8.16.1 C.R. Bard Company Information
- 8.16.2 C.R. Bard Business Overview
- 8.16.3 C.R. Bard Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.16.4 C.R. Bard Radiation Oncology Devices Product Portfolio
- 8.16.5 C.R. Bard Recent Developments
- 8.17 Accuray Incorporated
- 8.17.1 Accuray Incorporated Company Information
- 8.17.2 Accuray Incorporated Business Overview
- 8.17.3 Accuray Incorporated Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Accuray Incorporated Radiation Oncology Devices Product Portfolio
- 8.17.5 Accuray Incorporated Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Radiation Oncology Devices Value Chain Analysis
- 9.1.1 Radiation Oncology Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radiation Oncology Devices Sales Mode & Process
- 9.2 Radiation Oncology Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radiation Oncology Devices Distributors
- 9.2.3 Radiation Oncology Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst